RxDoctor Payments Data

David Heath, MD

Orthopaedic Surgery · San Antonio, TXNPI 1861989246

Payments from drug & device makers

$39,399in general payments, 2019–2025

Across 87 payments — averaging $452.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$21K
  • Smith+Nephew$14K
  • Stryker$1K
  • Mission Medical Distribution, LLC$1K
  • Zimmer Biomet$927
  • Integra Lifesciences Corporation$389
  • plus $508 from 6 others

What the payments were for

  • Grants$26,25067%
  • Travel & lodging$3,1188%
  • Food & beverage$3,78110%
  • Education$6,25016%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex10$21,162
Smith+Nephew10$13,977
Stryker35$1,429
Mission Medical Distribution, LLC6$1,007
Zimmer Biomet11$927
Integra Lifesciences Corporation5$389
Sanara Medtech Inc.3$248
Lima USA, Inc.1$126
Bioventus LLC3$75
Haemonetics Corporation1$23
Medinc Of Texas1$20
Ferring Pharmaceuticals Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,399 in reported general payments places this provider in the 80th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$9,710
Medicare patients
32
Services billed
61

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron11$115
Naproxen12$75
Oxycodone Hcl11$64

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →